Welcome to our dedicated page for Trulieve Cannabis SEC filings (Ticker: TRLV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Trulieve Cannabis's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Trulieve Cannabis's regulatory disclosures and financial reporting.
Trulieve Cannabis Corp. ownership update: AdvisorShares Trust reports beneficial ownership of 10,641,152 subordinate voting shares, representing 6.26% of the class as of 06/30/2026. The filing shows sole voting and dispositive power over those shares.
Trulieve Cannabis Corp. reported a leadership change in its finance organization. As of June 30, 2026, the company eliminated the stand-alone role of Chief Accounting Officer and terminated Brett Walsh’s employment in that position without cause.
At the same time, Trulieve designated its Chief Financial Officer, Jan Reese, as principal accounting officer, consolidating the top finance and accounting responsibilities under one executive. The company noted that Reese will not receive any change or increase in compensation for assuming the additional accounting officer duties.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported an open-market sale of 136,811 Subordinate Voting Shares at a weighted average price of $8.756 per share. After this sale, she directly holds 1,476,913 Subordinate Voting Shares.
The sale was effected under a Rule 10b5-1 plan to sell 2.5 million shares that she adopted on March 16, 2026. A first tranche of 1,699,007 Subordinate Voting Shares under this plan has been completed, and she has notified the administering broker-dealer of her intention to terminate the plan on August 11, 2026 before any additional sales.
Rivers also has exposure through Multiple Voting Shares that are convertible into Subordinate Voting Shares on a one-for-100 basis, including holdings reported directly and indirectly via Traunch IV LLC, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported open-market sales of 1,080,000 Subordinate Voting Shares. She sold 380,000 shares at a weighted average price of $8.469 per share, 400,000 shares at $8.169 per share, and 300,000 shares also at $8.169 per share.
These sales were made under a Rule 10b5-1 plan adopted on March 16, 2026 to sell approximately 2.5 million shares, with a first tranche of 1,699,007 shares covered by a Form 144 filed on June 17, 2026. After these transactions, Rivers directly holds 1,613,724 Subordinate Voting Shares.
She also holds Multiple Voting Shares convertible into 15,166,700 Subordinate Voting Shares directly, and an additional 986,700 underlying Subordinate Voting Shares are held indirectly through Traunch IV LLC, where she may be deemed to exercise voting and investment control but disclaims beneficial ownership except for her pecuniary interest.
Trulieve Cannabis Corp. is asking shareholders to approve a Delaware Domestication, moving its corporate home from British Columbia to Delaware through a court-approved plan of arrangement. The change would keep each investor’s ownership percentage the same, converting existing Subordinate and Multiple Voting Shares into equivalent Delaware classes.
Management argues Delaware better matches Trulieve’s U.S.-based operations, U.S. legal and accounting framework, and NYSE listing, and could improve market acceptance and access to capital. The meeting will be held virtually on August 5, 2026, also seeking authority to adjourn if more time is needed to gather votes.
Trulieve Cannabis Corp. Chairman and CEO Kim A. Rivers reported open-market sales of 482,196 Subordinate Voting Shares. These sales occurred on June 17, 18 and 22, 2026 at weighted average prices around $9.35–$9.46 per share under transaction code S.
The filing notes these transactions were effected pursuant to a Rule 10b5-1 plan to sell 2.5 million shares adopted on March 16, 2026, with a Form 144 covering a first tranche of 1,699,007 Subordinate Voting Shares filed on June 17, 2026. Following the reported sales, Rivers directly holds 2,693,724 Subordinate Voting Shares.
She also has Multiple Voting Shares convertible into 15,166,700 Subordinate Voting Shares directly and 986,700 Subordinate Voting Shares indirectly through Traunch IV LLC, as disclosed in the derivative holdings and related footnotes.
Wilson Davis submitted a Form 144 notice relating to proposed sales of Subordinate Voting Shares of Trulieve Cannabis Corp. The filing lists multiple grant dates and share lots tied to RSU award agreements and a merger agreement, including several specific share amounts and dates.
The excerpt shows RSU-related lots such as 19,700 shares (12/29/2022), 44,354 shares (12/29/2023), 1,439,662 shares (09/17/2024), and others; additional lots include 59,301, 19,765, 98,289, and 17,936 with their respective award dates. The filer is identified at an address in Salt Lake City and the exchange listed is NYSE.